Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vectomega distribution deal

This article was originally published in The Tan Sheet

Executive Summary

New Chapter and EuroPharma have inked an agreement that appoints New Chapter as the exclusive distributor of the Green Bay, Wisc.-based ingredient supplier's Vectomega omega-3 phospholipid complex for the health food/natural product retail channel, the firms announce Sept. 8. The ingredient is a "natural marine complex" that is "50 times more absorbable across cellular membranes than other DHA/EPA products," according to EuroPharma (1"The Tan Sheet" July 17, 2006, p. 6). Vectomega delivers DHA and EPA in "their natural phospholipid form" without artificial modifications, a trait that fits with New Chapter's principle of providing whole-food products and supplements, the Brattleboro, Vt.-based manufacturer states. EuroPharma President Terry Lemerond and the principle scientists will promote the product with personal endorsements, "including public appearances at trade shows and industry events," and possible television and radio appearances, the firms state. Additional details about the agreement were not disclosed...

You may also be interested in...



R&D In Brief

Acetaminophen and ovarian cancer: A meta-analysis published in the July British Journal of Clinical Pharmacology "supports a protective association between acetaminophen use and ovarian cancer and provides evidence for a dose effect." However, the potential association between the drug and the disease "deserves further verification, since proof of chemoprevention would represent a major public health advance," Stefanos Bonovas, University of Athens, Greece, et al., state. Researchers analyzed eight studies (four case-control and four cohort studies) published between 1998 and 2004 and concluded that an inverse association exists between acetaminophen use and ovarian cancer risk. The association "was marginally significant assuming a random-effects model...but not statistically significant assuming a fixed-effects model"...

UK Regulator Puts Energies Into COVID-19 While Other Services May Take Longer

With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.

QUOTED. 3 April 2020. Minetta Liu.

Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.

Topics

UsernamePublicRestriction

Register

PS099769

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel